Mural Oncology plc
General ticker "MURA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $46.1M (TTM average)
Mural Oncology plc does not follow the US Stock Market performance with the rate: -11.7%.
Estimated limits based on current volatility of 0.1%: low 2.04$, high 2.04$
Factors to consider:
- Total employees count: 117 as of 2023
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.03$, 5.72$]
- 2025-12-31 to 2026-12-31 estimated range: [1.66$, 4.79$]
Short-term MURA quotes
Long-term MURA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $184.92MM | $194.64MM | $138.26MM |
| Operating Income | $-184.92MM | $-194.64MM | $-138.26MM |
| Non-Operating Income | $0.00MM | $-0.65MM | $9.75MM |
| R&D Expense | $167.19MM | $162.03MM | $110.67MM |
| Income(Loss) | $-184.92MM | $-195.29MM | $-128.51MM |
| Taxes | $4.88MM | $12.16MM | $0.00MM |
| Profit(Loss)* | $-189.81MM | $-207.45MM | $-128.51MM |
| Stockholders Equity | $-21.66MM | $263.82MM | $140.50MM |
| Assets | $33.75MM | $301.75MM | $169.39MM |
| Operating Cash Flow | $-168.59MM | $-194.25MM | $-128.54MM |
| Capital expenditure | $5.51MM | $3.45MM | $0.09MM |
| Investing Cash Flow | $-5.51MM | $-3.45MM | $-25.33MM |
| Financing Cash Flow | $174.10MM | $468.81MM | $0.20MM |
| Earnings Per Share** | $-11.37 | $-12.43 | $-7.58 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.